Barclays
DARE icon

Barclays’s Dare Bioscience DARE Stock Holding History

Barclays’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29
Closed -$1K – 4904
2021
Q1 		$1K Buy
+29
New +$707 ﹤0.01% 4587
2019
Q1 		– Sell
-1,167
Closed -$10K – 7057
2018
Q4 		$10K Buy
1,167
+700
+150% +$7.37K ﹤0.01% 6164
2018
Q3 		$5K Sell
467
-200
-30% -$2.69K ﹤0.01% 6773
2018
Q2 		$9K Sell
667
-666
-50% -$8.89K ﹤0.01% 6569
2018
Q1 		$13K Buy
+1,333
New +$27K ﹤0.01% 6578

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Barclays's DARE Position: Q2 2021 in Review

Barclays sold out of Dare Bioscience (DARE) in Q2 2021, closing a stake of 29 shares — an estimated $1K sold.

Barclays first reported a position in DARE in Q1 2018 and held it in 5 quarters. The position peaked at $13K in Q1 2018. 34 funds tracked by Wall St. Rank hold DARE as of Q2 2021.

  • Barclays reported no remaining Dare Bioscience position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 29 Dare Bioscience shares in Q2 2021, an estimated $1K.
  • Barclays first reported a position in Dare Bioscience in Q1 2018 and held it in 5 quarters.
  • Barclays's Dare Bioscience position peaked at $13K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.